featured
Regional Heterogeneity in the Efficacy of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant Data
Diabetes Care 2024 Nov 01;47(11)1949-1957, A Jullien, C Jambon-Barbara, JL Cracowski, BL Claggett, AL Borel, C Khouri, M RoustitFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.